TrialBlood advances2022

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2.

Kerry J Savage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.